High efficiency retroviral vectors that contain no viral coding sequences

Gene Therapy

Volumn 7, Issue 9, 2000, Pages 797-804

  Yu, S S ^a,b   Kim, J M ^b   Kim, S ^b  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Heterologous intron exon; MLV; Retroviral vector; Splicing

Indexed keywords

GAG PROTEIN; POL PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA PACKAGING; EXON; GENE EXPRESSION; GENETIC RECOMBINATION; INTRON; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RETROVIRUS; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALIA; MURINAE; MURINE LEUKEMIA VIRUS; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0034015319     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301164     Document Type: Article

References (23)

1. The Journal of Gene Medicine Website. (http://www.wiley. co.uk/genetherapy). Wiley.
2. Miller AD, Trauber DR, Buttimore C. Factors involved in production of helper virus free retrovirus vectors. Somat Cell Mol Genet 1986; 12: 175-183.
3. Muenchau DD et al. Analysis of retroviral packaging lines for generation of replication-competent virus. Virology 1990; 176: 262-265.
4. Otto E et al. Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences. Hum Gene Ther 1994; 5: 567-575.
5. Miller AD, Roseman GJ. Improved retroviral vectors for gene transfer and expression. Biotechniques 1989; 7: 980-990.
6. Armentano D et al. Effect of internal viral sequences on the utility of retroviral vectors. J Virol 1987; 61: 1647-1650.
7. Bender MA, Palmer TD, Gelinas RE, Miller AD. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J Virol 1987; 61: 1639-1646.
8. Kim SH et al. Construction of retroviral vectors with improved safety, gene expression, and versatility. J Virol 1998; 72: 994-1004.
9. Byun J et al. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy. Gene Therapy 1996; 3: 780-788.
10. Kral WJ et al. Increased levels of spliced RNA account for augmented expression from the MFC retroviral vector in hematopoietic cells. Gene Therapy 1995; 3: 37-48.
11. Dranoff G et al. Vaccination with irradiated tumor cells engineered to secrete murine GM-CSF stimulates potent, specific and long lasting antitumor immunity. Proc Natl Acad Sci USA 1993; 90: 3539-3543.
12. Ohashi T et al. Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector. Proc Natl Acad Sci USA 1992; 89: 11332-11336.
13. Ghattas IR, Sanes JR, Majors JE. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol Cell Biol 1991; 11: 5848-5859.
14. Kinsella TM, Nolan GP. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther 1996; 7: 1405-1413.
15. Soneoka Y et al. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 1995; 23: 628-633.
16. Thompson RC, Dripps DJ, Eisenberg SP. IL-1ra: properties and uses of an interleukin-1 receptor antagonist. Agents Actions Suppl 1991; 35: 41-49.
17. Cosset FL et al. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430-7436.
18. Finer MH et al. kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood 1994; 83: 43-50.
19. Wilson PJ et al. Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. Proc Natl Acad Sci USA 1990; 87: 8531-8535.
20. Horowitz M et al. The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics 1989; 4: 87-96.
21. Shinnick TM, Lerner RA, Sutcliffe JG. Nucleotide sequence of Moloney murine leukaemia virus. Nature 1981; 293: 543-548.
22. Biegalke BJ, Geballe AP. Sequence requirements for activation of the HIV-1 LTR by human cytomegalovirus. Virology 1991; 183: 381-385.
23. Pear WS, Nolan GP, Scott ML, Baltimore D. Production of hightiter helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 1993; 90: 8392-8396.